Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study - Zhou, Na; Hua, Yuwei; Ge, Yuping; Wang, Qiang; Wang, Chenyu; He, Jia; Zhao, Luo; Yu, Shuangni; Yan, Junfang; Zhao, Lin; Li, Li; Bai, Chunmei (Frontiers in Immunology, 2024)